GENOMICS MEDICINE INNOVATIONS: TRENDS SHAPING THE FUTURE OF HEALTHCARE AND BEYOND.
- Qatar Foundation, World Innovation Summit for Healthcare (WISH), P.O. Box: 5825, Doha, Qatar and Applied Biomedicine, Doha, Qatar.
- Qatar Medical Genetics Center (QMGC) and Interim Translational Research Institute (iTRI), HMC, P.O. Box 3050, Doha-Qatar, and Applied Biomedicine, Doha, Qatar.
- Abstract
- Keywords
- References
- Cite This Article as
- Corresponding Author
Extraordinary developments in genomics research, technologies and ensuing knowledge are creating the potential of astonishing changes in both the healthcare and the life sciences sectors. For instance, next generation sequencer technology is technically progressing at a very rapid pace making it multiple folds faster than five years ago. The genomics innovations include the following: 1) Adoption of Next Generation Sequencing (NGS) ? based testing such as Whole Exome and Genomic Sequencing (WES & WGS) in clinical service as a diagnostic test including so-called direct-to-consumer genetic testing services, 2) Moving toward single cell sequencing study in heterogeneous cells and/or genetic make-ups, 3) Evolution of NGS ? based RNA sequencing field, i.e., measuring the gene expression changes along with non-coding RNA (Whole Transcriptome Sequencing), 4) Pharmacogenomics, and 5) Circulating Tumor Cells (CTCs), circulating cell-free DNA (cfDNA), and mitochondrial DNA (mtDNA) as non-invasive real-time circulating blood biomarkers surrogates for tissues. This paper looks at the impact of clinical genomics disruptive innovations on the healthcare system in order to provide better diagnosis and treatment. The genomic trends will not only transform point-of-care but also it will further facilitate progression towards personalized medicine to offer tailored and/or targeted treatment to patients, i.e., personalized therapy with the promise to improve patient?s lives. A special reference will be made to the Gulf region genome projects and personalized healthcare plans for ultimately to offer better prevention, diagnosis and treatment for its population. In particular, Qatar?s efforts in the genomic medicine area will be emphasized including the private Applied Biomedicine Initiative (ABI).
- Ahmed, S., Zhou, Z., Zhou, J., & Chen, S. Q. (2016). Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics Proteomics Bioinformatics, 14(5), 298-313. doi:10.1016/j.gpb.2016.03.008
- Al-Dewik, N. (2013). Molecular stratification of myeloproliferative neoplasms (MPNs) patients in the State of Qatar according to World Health Organization (WHO) 2008 Criteria. Qatar Foundation Annual Research Forum Proceedings, BIOP 0190. doi:10.5339/qfarf. 2013. BIOP-0190
- Al-Dewik, N., & Moghaddam, P. (2017). Nutrigenomics: A Transnational Initiative to Personalizing Individuals? Lifestyle Based on Genetic Makeup. Paper presented at the Conference on Understanding molecular mechanisms underlying cardiovascular disease, Diabetes, Obesity and Stroke (CUDOS 2017), Shangri-La Hotel Diplomatic Area.
- Al-Dewik, N. I., Cassinat, B., Kiladjian, J.-J., Knuth, A., & Yassin, M. A. (2014). Targeted Exome Sequencing Identifies Novel Mutations in Familial Myeloproliferative Neoplasms Patients in the State of Qatar. Blood, 124(21), 5570-5570.
- Al-Mulla, F. (2014). The locked genomes: A perspective from Arabia. Appl Transl Genom, 3(4), 132-133. doi:10.1016/j.atg.2014.09.012
- Al-Shamsi, A., Hertecant, J. L., Souid, A. K., & Al-Jasmi, F. A. (2016). Whole exome sequencing diagnosis of inborn errors of metabolism and other disorders in United Arab Emirates. Orphanet J Rare Dis, 11(1), 94. doi:10.1186/s13023-016-0474-3
- Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H., Coulson, A. R., Drouin, J., . . . Young, I. G. (1981). Sequence and organization of the human mitochondrial genome. Nature, 290(5806), 457-465.
- Astley, S. B. (2007). An introduction to nutrigenomics developments and trends. Genes & Nutrition, 2(1), 11-13. doi:10.1007/s12263-007-0011-z
- Bartel, D. P. (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 116(2), 281-297.
- Basak, R., Nair, N. K., & Mittra, I. (2016). Evidence for cell-free nucleic acids as continuously arising endogenous DNA mutagens. Mutat Res, 793-794, 15-21. doi:10.1016/j.mrfmmm. 2016.10.002
- Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Cancer Genome, P. (2005). Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet, 365(9464), 1054-1061. doi:10.1016/S0140-6736(05)71142-9
- Baylin, S. B., & Jones, P. A. (2011). A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer, 11(10), 726-734. doi:10.1038/nrc3130
- Bertier, G., Hetu, M., & Joly, Y. (2016). Unsolved challenges of clinical whole-exome sequencing: a systematic literature review of end-users' views. BMC Med Genomics, 9(1), 52. doi:10.1186/s12920-016-0213-6
- Bonetta, L. (2010). Whole-genome sequencing breaks the cost barrier. Cell, 141(6), 917-919. doi:10.1016/j.cell.2010.05.034
- Buenrostro, J. D., Wu, B., Litzenburger, U. M., Ruff, D., Gonzales, M. L., Snyder, M. P., . . . Greenleaf, W. J. (2015). Single-cell chromatin accessibility reveals principles of regulatory variation. Nature, 523(7561), 486-490. doi:10.1038/nature14590
- Casneuf, T., Van de Peer, Y., & Huber, W. (2007). In situ analysis of cross-hybridisation on microarrays and the inference of expression correlation. BMC Bioinformatics, 8, 461. doi:10.1186/1471-2105-8-461
- (2013). Circulating Tumor Cell Kit Retrieved from www.cellsearchctc.com
- Charng, W.-L., Karaca, E., Coban Akdemir, Z., Gambin, T., Atik, M. M., Gu, S., . . . Lupski, J. R. (2016). Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate. BMC Medical Genomics, 9, 42. doi:10.1186/s12920-016-0208-3
- Chu, Y., & Corey, D. R. (2012). RNA Sequencing: Platform Selection, Experimental Design, and Data Interpretation. Nucleic Acid Therapeutics, 22(4), 271-274. doi:10.1089/nat.2012.0367
- (2017). Synopsis of the Research Project ?Indigenizing Genomics in the Gulf Region (IGGR): The Missing Islamic Bioethical Discourse. Retrieved from https://www.cilecenter.org/en/news/synopsis-research-project-indigenizing-genomics-gulf-region-iggr-missing-islamic-bioethical-discourse/
- (2017). Conference on Understanding molecular mechanisms underlying cardiovascular disease, Diabetes, Obesity and Stroke Conference and Workshop Program. Retrieved from http://events.sidra.org/event/cudos-2017/
- Cusanovich, D. A., Daza, R., Adey, A., Pliner, H. A., Christiansen, L., Gunderson, K. L., . . . Shendure, J. (2015). Multiplex single cell profiling of chromatin accessibility by combinatorial cellular indexing. Science, 348(6237), 910-914. doi:10.1126/science.aab1601
- Darley-Usmar, V. (2004). The powerhouse takes control of the cell; the role of mitochondria in signal transduction. Free Radic Biol Med, 37(6), 753-754. doi:10.1016/j.freeradbiomed.2004.05.026
- Eberwine, J., Sul, J. Y., Bartfai, T., & Kim, J. (2014). The promise of single-cell sequencing. Nat Methods, 11(1), 25-27.
- El Bashir, H., Dekair, L., Mahmoud, Y., & Ben-Omran, T. (2015). Neurodevelopmental and Cognitive Outcomes of Classical Homocystinuria: Experience from Qatar. JIMD Rep, 21, 89-95. doi:10.1007/8904_2014_394
- El-Khadem, H., Ben-Omran, T., Al-Dewik , N., Kruger, W., Henk, B., & Nasrallah, G. (2017). Novel therapies for Qatari patients with Homocystinuria. Paper presented at the The Second Annual Health Research Symposium at Qatar University, atar University, College of Medicine - Bldg. (H12) - Room 126,.
- Fattahi, Z., Kalhor, Z., Fadaee, M., Vazehan, R., Parsimehr, E., Abolhassani, A., . . . Najmabadi, H. (2016). Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population. Clin Genet. doi:10.1111/cge.12810
- Goodwin, S., McPherson, J. D., & McCombie, W. R. (2016). Coming of age: ten years of next-generation sequencing technologies. Nat Rev Genet, 17(6), 333-351. doi:10.1038/nrg.2016.49
- (2013). Qatar launches genome project.
- Gupta, A. K., & Gupta, U. D. (2014). Chapter 19 - Next Generation Sequencing and Its Applications A2 - Verma, Ashish S. In A. Singh (Ed.), Animal Biotechnology (pp. 345-367). San Diego: Academic Press.
- Gupta, G. P., & Massague, J. (2006). Cancer metastasis: building a framework. Cell, 127(4), 679-695. doi:10.1016/j.cell.2006.11.001
- Hamblin, A., Wordsworth, S., Fermont, J. M., Page, S., Kaur, K., Camps, C., . . . Schuh, A. (2017). Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service. PLoS Med, 14(2), e1002230. doi:10.1371/journal.pmed.1002230
- (2015). The 9th Scientific Conference: Princess Al Jawhara Center for Molecular Medicine:Towards Bahrain Genome Project: Insights from International Experiences. Retrieved from https://sites.google.com/a/agu.edu.bh/aljawhara/events
- Hodson, R. (2016). Precision medicine. Nature, 537(7619), S49. doi:10.1038/537S49a
- Hood, L., & Flores, M. (2012). A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol, 29(6), 613-624. doi:10.1016/j.nbt.2012.03.004
- Hood, L., & Galas, D. (2003). The digital code of DNA. Nature, 421(6921), 444-448. doi:10.1038/nature01410
- Iborra, F. J., Kimura, H., & Cook, P. R. (2004). The functional organization of mitochondrial genomes in human cells. BMC Biology, 2, 9-9. doi:10.1186/1741-7007-2-9
- James, C., Ugo, V., Casadevall, N., Constantinescu, S. N., & Vainchenker, W. (2005). A JAK2 mutation in myeloproliferative disorders: pathogenesis and therapeutic and scientific prospects. Trends Mol Med, 11(12), 546-554. doi:10.1016/j.molmed.2005.10.003
- Jeck, W. R., Sorrentino, J. A., Wang, K., Slevin, M. K., Burd, C. E., Liu, J., . . . Sharpless, N. E. (2013). Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA, 19(2), 141-157. doi:10.1261/rna.035667.112
- Jin, W., Tang, Q., Wan, M., Cui, K., Zhang, Y., Ren, G., . . . Zhao, K. (2015). Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples. Nature, 528(7580), 142-146. doi:10.1038/nature15740
- Kralovics, R., Passamonti, F., Buser, A. S., Teo, S. S., Tiedt, R., Passweg, J. R., . . . Skoda, R. C. (2005). A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med, 352(17), 1779-1790. doi:10.1056/NEJMoa051113
- Kralovics, R., Teo, S. S., Buser, A. S., Brutsche, M., Tiedt, R., Tichelli, A., . . . Skoda, R. C. (2005). Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood, 106(10), 3374-3376. doi:10.1182/blood-2005-05-1889
- Kukurba, K. R., & Montgomery, S. B. (2015). RNA Sequencing and Analysis. Cold Spring Harbor protocols, 2015(11), 951-969. doi:10.1101/pdb.top084970
- Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., . . . International Human Genome Sequencing, C. (2001). Initial sequencing and analysis of the human genome. Nature, 409(6822), 860-921. doi:10.1038/35057062
- Levine, R. L., Wadleigh, M., Cools, J., Ebert, B. L., Wernig, G., Huntly, B. J., . . . Gilliland, D. G. (2005). Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell, 7(4), 387-397. doi:10.1016/j.ccr.2005.03.023
- Linnarsson, S., & Teichmann, S. A. (2016). Single-cell genomics: coming of age. Genome Biol, 17, 97. doi:10.1186/s13059-016-0960-x
- Lister, R., Pelizzola, M., Dowen, R. H., Hawkins, R. D., Hon, G., Tonti-Filippini, J., . . . Ecker, J. R. (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 462(7271), 315-322. doi:http://www.nature.com/nature/journal/v462/n7271/suppinfo/nature08514_S1.html
- Lu, Y.-F., Goldstein, D. B., Angrist, M., & Cavalleri, G. (2014). Personalized Medicine and Human Genetic Diversity. Cold Spring Harbor Perspectives in Medicine, 4(9), a008581. doi:10.1101/cshperspect.a008581
- Madsen, A. M. R., Holm, A., Jensen, T. G., Knudsen, E., Lundgaard, H., Skov, M. N., . . . Kemp, M. (2017). Whole Genome Sequencing for identification of the source in hospital-acquired Legionnaires? Disease. Journal of Hospital Infection. doi:https://doi.org/10.1016/j.jhin.2017.04.020
- Marian, A. J. (2014). Sequencing Your Genome: What Does It Mean? Methodist DeBakey Cardiovascular Journal, 10(1), 3-6.
- Method of the year 2013. (2014). Nat Methods, 11(1), 1.
- MOH&P-UAE. (2017). Ministry of Health and Prevention reveals UAE Human Genome Project at ?Arab Health 2017? in Dubai. Retrieved from http://www.moh.gov.ae/en/News/Pages/NewsDetail.aspx?itemID=621
- Mooney, S. D. (2015). Progress towards the integration of pharmacogenomics in practice. Hum Genet, 134(5), 459-465. doi:10.1007/s00439-014-1484-7
- Muller, M., & Kersten, S. (2003). Nutrigenomics: goals and strategies. Nat Rev Genet, 4(4), 315-322. doi:10.1038/nrg1047
- Al-Dewik, Q. F., YK. Naidu, N. Bonnin, E. Verger, B. Cassinat, JJ. Kiladjian, H. El Ayoubi, M. Yassin. (2013). Molecular Classification of Myeloproliferative Neoplasms (MPNs) Patients in the State of Qatar According to World Health Organization (WHO) 2008 Criteria. Paper presented at the The American Society of Human Genetics (ASHG 2013) Annual Meeting, USA.
- Nawy, T. (2014). Single-cell sequencing. Nat Methods, 11(1), 18.
- (2017). Precision Medicine. Retrieved from https://ghr.nlm.nih.gov/
- NIH-NHGRI. (2015). All About The Human Genome Project (HGP). Retrieved from https://www.genome.gov/10001772/all-about-the--human-genome-project-hgp/
- Palmisano, W. A., Divine, K. K., Saccomanno, G., Gilliland, F. D., Baylin, S. B., Herman, J. G., & Belinsky, S. A. (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res, 60(21), 5954-5958.
- Pardanani, A. D., Levine, R. L., Lasho, T., Pikman, Y., Mesa, R. A., Wadleigh, M., . . . Tefferi, A. (2006). MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients. Blood, 108(10), 3472-3476. doi:10.1182/blood-2006-04-018879
- Parr, R. L., & Martin, L. H. (2012). Mitochondrial and nuclear genomics and the emergence of personalized medicine. Hum Genomics, 6, 3. doi:10.1186/1479-7364-6-3
- Paterlini-Brechot, P., & Benali, N. L. (2007). Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett, 253(2), 180-204. doi:10.1016/j.canlet.2006.12.014
- Pikman, Y., Lee, B. H., Mercher, T., McDowell, E., Ebert, B. L., Gozo, M., . . . Levine, R. L. (2006). MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia. PLoS Med, 3(7), e270. doi:10.1371/journal.pmed.0030270
- Pilotto, A., Panza, F., & Seripa, D. (2011). Pharmacogenetics in geriatric medicine: challenges and opportunities for clinical practice. Curr Drug Metab, 12(7), 621-634.
- Płoski, R. (2016). Chapter 1 - Next Generation Sequencing?General Information about the Technology, Possibilities, and Limitations. In Clinical Applications for Next-Generation Sequencing (pp. 1-18). Boston: Academic Press.
- (2015). Qatar Science and Technology Park celebrate first Accelerator Programme graduates with a Demo Day. Retrieved from http://www.qstp.org.qa/home/stay-informed/press-release/press-releases-detail/2015/07/01/qatar-science-and-technology-park-celebrate-first-accelerator-programme-graduates-with-a-demo-day
- Quail, M. A., Smith, M., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., . . . Gu, Y. (2012). A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341. doi:10.1186/1471-2164-13-341
- Rinn, J. L., & Chang, H. Y. (2012). Genome regulation by long noncoding RNAs. Annual review of biochemistry, 81, 10.1146/annurev-biochem-051410-092902. doi:10.1146/annurev-biochem-051410-092902
- Riquet, M., Rivera, C., Gibault, L., Pricopi, C., Mordant, P., Badia, A., . . . Le Pimpec Barthes, F. (2014). [Lymphatic spread of lung cancer: anatomical lymph node chains unchained in zones]. Rev Pneumol Clin, 70(1-2), 16-25. doi:10.1016/j.pneumo.2013.07.001
- Roses, A. D. (2000). Pharmacogenetics and the practice of medicine. Nature, 405(6788), 857-865. doi:10.1038/35015728
- Sadoun, E., Alkuraya, F., Fakhro, K., Zawati, M. n., Ismail, S., & Ben-Omran, T. (2016). GENOMICS IN THE GULF REGION AND ISLAMIC ETHICS. Retrieved from https://www.imperial.ac.uk/media/imperial-college/institute-of-global-health-innovation/Islamic-Ethics-Report-English-(1).pdf
- Saudi Mendeliome, G. (2015a). Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases. Genome Biol, 16, 134. doi:10.1186/s13059-015-0693-2
- Saudi Mendeliome, G. (2015b). Erratum to: Comprehensive gene panels provide advantages over clinical exome sequencing for Mendelian diseases. Genome Biol, 16, 226. doi:10.1186/s13059-015-0798-7
- Saunders, C. J., Miller, N. A., Soden, S. E., Dinwiddie, D. L., Noll, A., Alnadi, N. A., . . . Kingsmore, S. F. (2012). Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units. Science Translational Medicine, 4(154), 154ra135-154ra135. doi:10.1126/scitranslmed.3004041
- Schones, D. E., & Zhao, K. (2008). Genome-wide approaches to studying chromatin modifications. Nat Rev Genet, 9(3), 179-191. doi:10.1038/nrg2270
- Scott, L. M., Tong, W., Levine, R. L., Scott, M. A., Beer, P. A., Stratton, M. R., . . . Green, A. R. (2007). JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med, 356(5), 459-468. doi:10.1056/NEJMoa065202
- Shendure, J. (2008). The beginning of the end for microarrays? Nat Methods, 5(7), 585-587. doi:10.1038/nmeth0708-585
- Shendure, J., & Ji, H. (2008). Next-generation DNA sequencing. Nat Biotechnol, 26(10), 1135-1145. doi:10.1038/nbt1486
- Smallwood, S. A., Lee, H. J., Angermueller, C., Krueger, F., Saadeh, H., Peat, J., . . . Kelsey, G. (2014). Single-cell genome-wide bisulfite sequencing for assessing epigenetic heterogeneity. Nat Methods, 11(8), 817-820. doi:10.1038/nmeth.3035
- Swarup, V., & Rajeswari, M. R. (2007). Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett, 581(5), 795-799. doi:10.1016/j.febslet.2007.01.051
- Tefferi, A., & Vardiman, J. W. (2008). Classification and diagnosis of myeloproliferative neoplasms: the 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia, 22(1), 14-22. doi:10.1038/sj.leu.2404955
- van der Vaart, M., & Pretorius, P. J. (2007). The origin of circulating free DNA. Clin Chem, 53(12), 2215. doi:10.1373/clinchem.2007.092734
- Vannucchi, A. M., Guglielmelli, P., & Tefferi, A. (2009). Advances in understanding and management of myeloproliferative neoplasms. CA Cancer J Clin, 59(3), 171-191. doi:10.3322/caac.20009
- Verger, E., Cassinat, B., Chauveau, A., Dosquet, C., Giraudier, S., Schlageter, M. H., . . . Kiladjian, J. J. (2015). Clinical and molecular response to interferon-alpha therapy in essential thrombocythemia patients with CALR mutations. Blood, 126(24), 2585-2591. doi:10.1182/blood-2015-07-659060
- Wang, Z., Gerstein, M., & Snyder, M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet, 10(1), 57-63. doi:10.1038/nrg2484
- Wetterstrand, K. (2016). DNA Sequencing Costs: Data. Retrieved from http://www.genome.gov/sequencingcostsdata
- (2002). Genomics and World Health (92-4-154554-2). Retrieved from Geneva: http://www.who.int/entity/rpc/genomics_report.pdf
- Witney, A. A., Cosgrove, C. A., Arnold, A., Hinds, J., Stoker, N. G., & Butcher, P. D. (2016). Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC Medicine, 14(1), 46. doi:10.1186/s12916-016-0598-2
- Xia, M., Li, H., Ma, Q., Yu, D., Li, J., Zhang, Y., . . . Guo, Y. (2017). Identifying the clonal relationship model of multifocal papillary thyroid carcinoma by whole genome sequencing. Cancer Letters, 396, 110-116. doi:https://doi.org/10.1016/j.canlet.2017.03.012
- Yassin, M. A., & Al-Dewik, N. I. (2016). Clinical Exome Sequencing Unravels New Disease Causing Mutations in Myeloproliferative Neoplasms (MPNs): A Pilot Study in Patients from the State of Qatar. Blood, 128(22), 5520-5520.
- Yassin, M. A., Al-Dewik, N. I., ElAyoubi, H., & Cassinat, B. (2013). Familial Essential Thrombocythemia Among Qatari Tribes. Blood, 122(21), 5244-5244.
- Yavarna T and Al-Dewik, N., Al-Mureikhi, M., Ali, R., Al-Mesaifri, F., Mahmoud, L., Shahbeck, N., . . . Ben-Omran, T. (2015). High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum Genet, 134(9), 967-980. doi:10.1007/s00439-015-1575-0
- Zhao, S., Fung-Leung, W. P., Bittner, A., Ngo, K., & Liu, X. (2014). Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One, 9(1), e78644. doi:10.1371/journal.pone.0078644
[M. Walid Qoronfleh and Nader I Al-Dewik. (2017); GENOMICS MEDICINE INNOVATIONS: TRENDS SHAPING THE FUTURE OF HEALTHCARE AND BEYOND. Int. J. of Adv. Res. 5 (Oct). 1310-1325] (ISSN 2320-5407). www.journalijar.com
Qatar Foundation, World Innovation Summit for Healthcare (WISH), P.O. Box: 5825, Doha, Qatar